Catalyst Pharmaceuticals Inc (CPRX.OQ) Analyst Research| Reuters.com
Edition:
United States

Catalyst Pharmaceuticals Inc (CPRX.OQ)

CPRX.OQ on NASDAQ Stock Exchange Capital Market

0.80USD
10:38am EDT
Change (% chg)

$0.01 (+0.89%)
Prev Close
$0.79
Open
$0.79
Day's High
$0.80
Day's Low
$0.76
Volume
24,788
Avg. Vol
227,075
52-wk High
$5.80
52-wk Low
$0.51

Reports per page
Select Report Title Date Provider Pgs Price
Thomson Reuters Stock Report - Catalyst Pharmaceuticals Inc (CPRX-O) 26 Jun 2016 Thomson Reuters Stock Report 12 25.00
ValuEngine Rating and Forecast Report for CPRX 25 Jun 2016 ValuEngine, Inc. 11 25.00
Catalyst Pharmaceutical 25 Jun 2016 S&P Capital IQ Quantitative Report 10 115.00
COMPSCRIPT INC (CPRX=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS 24 Jun 2016 Pechala's Reports 2 25.00
Catalyst Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 24 Jun 2016 Reuters Investment Profile 12 20.00
Value Graph: CATALYST PHARMA -- CPRX 23 Jun 2016 Ford Investor Services, Inc. 1 12.00
Thomson Reuters Stock Report - Catalyst Pharmaceuticals Inc (CPRX-O) 10 May 2016 Thomson Reuters Stock Report 12 25.00
Catalyst Pharmaceutical Partners, Inc. (CPRX) - Financial and Strategic SWOT Analysis Review 2 May 2016 GlobalData 61 300.00
CPRX.OQ - Event Transcript of Catalyst Pharmaceuticals Inc conference call, Mar. 16, 2016 / 8:30AM ET 16 Mar 2016 Thomson Reuters StreetEvents 7 75.00
 
Name Age Since Current Position

Patrick McEnany

68 2006 Chairman of the Board, President, Chief Executive Officer

Alicia Grande

44 2011 Chief Financial Officer, Vice President, Treasurer

Steven Miller

53 2011 Chief Operating Officer, Chief Scientific Officer

David Muth

60 2015 Executive Vice President, Chief Commercial Officer

M. Douglas Winship

66 2006 Vice President - Regulatory Operations